Dalteparin
Drug timelines are a Plus or Pro feature.
18 regulatory and trial events tracked for Dalteparin, covering 2008-05-21 to 2026-04-17. Get the full timeline:
Most recent: Clinical Trial Update: A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE [Phase 3]